Log in
Enquire now
‌

US Patent 11890277 Ophthalmic composition

Patent 11890277 was granted and assigned to Sydnexis on February, 2024 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors
Is a
Patent
Patent
0
Current Assignee
Sydnexis
Sydnexis
0
Date Filed
November 16, 2022
0
Date of Patent
February 6, 2024
0
Patent Applicant
Sydnexis
Sydnexis
0
Patent Application Number
18055940
0
Patent Citations
‌
US Patent 8404271 Contact drug delivery system
0
‌
US Patent 7691099 Deuterated ocular solutions for LTK and other surgical eye procedures
0
‌
US Patent 7858582 Ophthalmic hGM-CSF preparation
0
‌
US Patent 8333985 Non-glycerol stabilized bone graft
0
‌
US Patent 10888557 Ophthalmic composition
0
‌
US Patent 10940145 Ophthalmic composition
0
‌
US Patent 10953002 Ophthalmic composition
0
‌
US Patent 11052094 D
0
‌
US Patent 11052095 D2O stabilized pharmaceutical formulations
0
‌
US Patent 11382909 Ophthalmic composition
0
•••
Patent Inventor Names
David S. Baker
0
Gregory I. Ostrow
0
Kenneth J. Widder
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
11890277
0
Patent Primary Examiner
‌
Gina C Justice
0
CPC Code
‌
A61K 9/0048
0

Find more entities like US Patent 11890277 Ophthalmic composition

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo
By using this site, you agree to our Terms of Service.